Your browser doesn't support javascript.
loading
Changes of plasminogen activator inhibitor-1 and D-dimer during continuous blood purification and related factors / 中南大学学报(医学版)
Journal of Central South University(Medical Sciences) ; (12): 67-72, 2014.
Article in Chinese | WPRIM | ID: wpr-815461
ABSTRACT
OBJECTIVE@#To observe the changes of plasminogen activator inhibitor-1 and D-dimer during continuous blood purification (CBP) and related factors.@*METHODS@#Sixteen patients who were diagnosed with multiple organ dysfunction syndrome (MODS) were randomly divided into 2 groups 8 patients received standard continuous blood purification with heparin anticoagulation, and the other 8 received CBP without anticoagulation. Ten normal blood samples were collected from healthy volunteers as controls. All patients underwent CBP for 8 h. Blood was taken from those patients at 0, 15, 60, 120 and 480 min during the CBP. Plasma plasminogen activator inhibitor-1, D-dimer and serum TNF-α and IL-1β were measured by ELISA.@*RESULTS@#Plasma levels of PAI-1 and D-dimer were increased significantly compared with those in the control group (P<0.05). Plasma level of PAI-1 was reduced (P<0.05) and D-dimer was increased (P<0.05) after the CBP. The level of plasma PAI-1 in the heparin group was significant reduced compared with the group of CBP without anticoagulation (P<0.05). There was negative correlation between the level of PAI-1 and the dosage of heparin used during a CBP session in the heparin group (r=-0.746, P<0.001).@*CONCLUSION@#The level of PAI-1 and D-dimer is higher in patients with MODS than that in the normal controls. After the CBP treatment, there is significant decrease in PAI-1 and increase in D-dimer in both groups. Heparin used during CBP can reduce PAI-1 which intensifies its function of anticoagulation.
Subject(s)
Full text: Available Index: WPRIM (Western Pacific) Main subject: Blood / Fibrin Fibrinogen Degradation Products / Heparin / Renal Dialysis / Tumor Necrosis Factor-alpha / Plasminogen Activator Inhibitor 1 / Therapeutic Uses / Interleukin-1beta / Anticoagulants Limits: Humans Language: Chinese Journal: Journal of Central South University(Medical Sciences) Year: 2014 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Blood / Fibrin Fibrinogen Degradation Products / Heparin / Renal Dialysis / Tumor Necrosis Factor-alpha / Plasminogen Activator Inhibitor 1 / Therapeutic Uses / Interleukin-1beta / Anticoagulants Limits: Humans Language: Chinese Journal: Journal of Central South University(Medical Sciences) Year: 2014 Type: Article